Are healthcare stocks underperforming Biodesix (BDSX) so far this year?

Biodesix, Inc.: Outperforming in the Medical Sector

While the Medical sector offers a wide array of promising stocks, it's important for investors to identify those that are excelling compared to their industry peers. Biodesix, Inc. (BDSX) stands out as a potential leader, especially when examining its performance so far this year against the broader Medical sector.

Among the 928 companies that make up the Medical sector, Biodesix, Inc. is notable. The sector itself currently holds the #9 spot in the Zacks Sector Rank, which evaluates 16 sectors based on the average Zacks Rank of their constituent stocks to determine overall strength.

The Zacks Rank system, which focuses on earnings projections and their revisions, is a trusted method for identifying stocks with the potential to outperform the market in the short term. At present, Biodesix, Inc. has achieved a Zacks Rank of #2 (Buy).

Over the last quarter, analysts have raised their full-year earnings estimates for BDSX by 3.5%, indicating growing optimism and an improving earnings outlook for the company.

Year-to-date, Biodesix, Inc. has surged approximately 131.6%, far outpacing the average 1.9% return posted by other Medical sector stocks. This impressive growth highlights BDSX’s strong performance within its sector.

Other Noteworthy Performers

Cabaletta Bio, Inc. (CABA) is another Medical stock that has delivered notable returns this year, climbing 50.7% since the start of the year.

Analyst expectations for Cabaletta Bio, Inc.'s earnings per share have also improved, rising 1.6% over the last three months. The company currently shares the same Zacks Rank of #2 (Buy) as Biodesix.

Industry Breakdown

Biodesix, Inc. operates within the Medical Services industry, which comprises 66 companies and is currently ranked #90 by Zacks. On average, stocks in this group have declined by 2.5% this year, making BDSX’s positive returns even more remarkable.

Meanwhile, Cabaletta Bio, Inc. is part of the Medical - Biomedical and Genetics industry, which includes 447 companies and is ranked #137. This industry has seen an average gain of 8.7% since the beginning of the year.

Looking Ahead

Investors interested in the Medical sector should keep a close watch on both Biodesix, Inc. and Cabaletta Bio, Inc., as their strong momentum may continue in the coming months.